SeptRx
United states-based medical device company developing minimally invasive treatments for structural heart defects.
Launch date
Employees
Market cap
-
Enterprise valuation
$11—16m (Dealroom.co estimates Jun 2011.)
Fremont California (HQ)
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.